Literature DB >> 22874475

The role of glia in late-life depression.

Matt Bennett Paradise1, Sharon Linda Naismith, Louisa Margaret Norrie, Manuel Benedikt Graeber, Ian Bernard Hickie.   

Abstract

Late-life depression (LLD) has a complex and multifactoral etiology. There is growing interest in elucidating how glia, acting alone or as part of a glial-neuronal network, may contribute to the pathophysiology of depression. In this paper, we explore results from neuroimaging studies showing gray-matter volume loss in key frontal and subcortical structures implicated in LLD, and present the few histological studies that have examined neuronal and glial densities in these regions. Compared to results in younger people with depression, there appear to be age-dependent differences in neuronal pathology but the changes in glial pathology may be more subtle, perhaps reflecting a longer-term compensatory gliosis to earlier damage. We then consider the mechanisms by which both astrocytes and microglia may mediate and modulate neuronal dysfunction and possible degeneration in depression. These include a critical role in the response to peripheral inflammation and central microglial activation, as well as a key role in glutamate metabolism. Advances in our understanding of glia are highlighted, including the role of microglia as "electricians" of the brain and astrocytes as key communicating cells, an integral part of the tripartite synapse. Finally, implications for clinicians are discussed, including the consideration of glia as biomarkers for LLD and incorporation of glia into future therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22874475     DOI: 10.1017/S1041610212000828

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  16 in total

Review 1.  Astrogliosis.

Authors:  Michael V Sofroniew
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-11-07       Impact factor: 10.005

2.  Organic bases of late-life depression: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2013-01-25       Impact factor: 3.575

3.  Inflammation is increased with anxiety- and depression-like signs in a rat model of spinal cord injury.

Authors:  Sioui Maldonado-Bouchard; Kelsey Peters; Sarah A Woller; Behrouz Madahian; Usef Faghihi; Shivani Patel; Shameena Bake; Michelle A Hook
Journal:  Brain Behav Immun       Date:  2015-08-18       Impact factor: 7.217

4.  Cognitive impairment with and without depression history: an analysis of white matter microstructure.

Authors:  Shantel L Duffy; Matt Paradise; Ian B Hickie; Simon J G Lewis; Sharon L Naismith; Jim Lagopoulos
Journal:  J Psychiatry Neurosci       Date:  2014-03       Impact factor: 6.186

Review 5.  Astrocyte barriers to neurotoxic inflammation.

Authors:  Michael V Sofroniew
Journal:  Nat Rev Neurosci       Date:  2015-05       Impact factor: 34.870

Review 6.  The enigma of vascular depression in old age: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-15       Impact factor: 3.850

7.  Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients.

Authors:  Antonio Drago; Barbara Monti; Diana De Ronchi; Alessandro Serretti
Journal:  Neuropsychobiology       Date:  2014-02-27       Impact factor: 2.328

Review 8.  Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.

Authors:  Grazyna Rajkowska; Craig A Stockmeier
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465

9.  Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression.

Authors:  Ludger Tebartz van Elst; Dominique Endres; Maike Michel; Bernd L Fiebich; Hanna Kuzior; Sophie Meixensberger; Benjamin Berger; Simon Maier; Kathrin Nickel; Kimon Runge; Dominik Denzel; Benjamin Pankratz; Miriam A Schiele; Katharina Domschke
Journal:  Transl Psychiatry       Date:  2021-05-21       Impact factor: 6.222

10.  The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an older age cohort at risk for depression: study protocol for a randomized controlled trial.

Authors:  Nicole L Cockayne; Shantel L Duffy; Rosalind Bonomally; Amelia English; Paul G Amminger; Andrew Mackinnon; Helen M Christensen; Sharon L Naismith; Ian B Hickie
Journal:  Trials       Date:  2015-06-03       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.